This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Bonnie J. Addario Reflects On The Passing Of Singer Bobbie Smith

Recent news of high-profile lung cancer cases and deaths highlights need for more funding and better research

SAN CARLOS, Calif., March 26, 2013 /PRNewswire-USNewswire/ -- The following statement was issued by Bonnie J. Addario in light of Bobbie Smith, lead singer of The Spinners, losing his battle with lung cancer last week:


"Lung cancer has been in the news a lot lately, with high-profile celebrities like Valerie Harper, revealing her lung cancer has now metastasized to her brain, the acclaimed opera singer Zheng Cao losing her fight with lung cancer last month, and now Bobbie Smith, the cherished voice of The Spinners, has also succumbed to the disease. It saddens me deeply that I have to read about these talented people. And what it shows is that anyone can get lung cancer. The numbers don't lie: Lung cancer kills more people every year than the next five biggest cancers combined. There are 1.4 million people worldwide with lung cancer. More women die every year from lung cancer than breast cancer. But 80 percent of newly diagnosed patients quit smoking years ago or never smoked at all. And the five-year survival rate has remained unchanged since 1971 – just 15 percent survive more than five years after being diagnosed.

"And still there is a stigma that it's a smoker's disease. This is proven by the disproportionate lack of funding given to lung cancer research. Moreover, doctors are often misinformed when it comes to treatment options and the value of early detection screenings and targeted therapies.

"It is time we stop singling out just lung cancer as a smoking disease. Smoking is also a cause of many other cancers, vascular disease and heart disease. It is time we get on with changing the survival rate of the biggest cancer in the world. The lack of funding for this disease is appalling and must increase to the level of breast, colon and prostate cancer. The high survival rates of these diseases are commensurate with the funding and amazing advocacy efforts.  

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs